Editas Medicine, Inc. (EDIT) Q3 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Editas Medicine, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:04.471 Good morning, and welcome to Editas Medicine's third quarter conference call. 00:00:04.471 -- 00:00:07.293 All participants are now in listen-only mode. 00:00:07.293 -- 00:00:10.454 There will be a question and answer session at the end of this call. 00:00:10.454 -- 00:00:14.896 Please be advised that this call is being recorded at the company's request. 00:00:14.896 -- 00:00:18.858 I would now like to turn the call over to Christy Barnett, Corporate Communications and 00:00:18.858 -- 00:00:22.299 Investor Relations at Editas Medicine. 00:00:22.740 -- 00:00:27.823 Thank you, Rob. Good morning, everyone, and welcome to our third quarter 2023 conference 00:00:27.823 -- 00:00:33.033 call. Earlier this morning, we issued a press release providing our financial results 00:00:33.033 -- 00:00:38.355 and recent corporate updates. A replay of today's call will be available in the investor 00:00:38.355 -- 00:00:43.238 section of our website approximately two hours after its completion. 00:00:43.238 -- 00:00:47.300 After our prepared remarks, we will open the call for Q&A. 00:00:47.300 -- 00:00:51.602 As a reminder, various remarks that we make during this call about the company's future 00:00:51.602 -- 00:00:56.821 expectations, plans, and prospects constitute forward-looking statements 00:00:56.821 -- 00:01:01.844 for the purposes of the safe harbor provisions under the Private Securities Litigation 00:01:01.844 -- 00:01:04.694 Reform Act of 1995. 00:01:04.885 -- 00:01:10.108 Actual results may differ materially from those indicated by these forward-looking statements 00:01:10.108 -- 00:01:15.211 as a result of various important factors, including those discussed in the risk factors 00:01:15.211 -- 00:01:20.413 section of our most recent an...